Tang Huidi, Li Kang, Wang Xiaojie
Department of Pharmacology, School of Basic Medical Sciences, Shandong University, Jinan, Shandong 250012, P.R. China.
Mol Med Rep. 2025 Sep;32(3). doi: 10.3892/mmr.2025.13614. Epub 2025 Jul 11.
Diabetic nephropathy (DN) is the main cause of end‑stage renal disease, with epithelial‑mesenchymal transition (EMT) serving a key role in its initiation and progression. Nevertheless, the precise mechanisms involved remain unidentified. The present study aimed to identify the involvement of EMT‑related genes in the advancement of DN. Using the Gene Expression Omnibus database and the dbEMT 2.0 database, EMT‑related differentially expressed genes (DEGs) associated with DN were identified. Key EMT‑related genes were subjected to weighted gene co‑expression network analysis, machine learning and protein‑protein interaction network analyses and validated against validation datasets from GEO database. Receiver operating characteristic analysis was used to assess the diagnostic performance of these hub genes. To delve into their cellular clustering in DN, single‑nucleus RNA sequencing was conducted using the Kidney Integrative Transcriptomics database. Additionally, the CIBERSORT algorithm was used to determine the proportion of immune cell infiltration in DN samples. Reverse transcription‑quantitative PCR (RT‑qPCR) was used to assess the mRNA expression of fibronectin 1 (FN1) in the kidney of mice and patients with DN. After silencing FN1, the expression changes of EMT markers (E‑cadherin and vimentin) were detected by RT‑qPCR. FN1 was upregulated in DN, demonstrating good diagnostic performance according to ROC analysis. FN1 was associated with infiltration of immune cells. RT‑qPCR confirmed the increased expression of FN1 in the kidney of mice with DN and in the renal biopsy samples of patients with DN. After silencing FN1, the expression of E‑cadherin was upregulated, while the expression of vimentin was downregulated, indicating that EMT was inhibited. The present study identified FN1 as a diagnostic marker for DN. FN1 may serve key roles in the initiation and progression of DN by participating in EMT and upregulating various types of immune cells.
糖尿病肾病(DN)是终末期肾病的主要原因,上皮-间质转化(EMT)在其发生和发展中起关键作用。然而,其确切机制仍不明晰。本研究旨在确定EMT相关基因在DN进展中的作用。利用基因表达综合数据库和dbEMT 2.0数据库,鉴定了与DN相关的EMT相关差异表达基因(DEG)。对关键的EMT相关基因进行加权基因共表达网络分析、机器学习和蛋白质-蛋白质相互作用网络分析,并根据来自GEO数据库的验证数据集进行验证。采用受试者工作特征分析评估这些枢纽基因的诊断性能。为深入研究它们在DN中的细胞聚类情况,使用肾脏综合转录组学数据库进行单核RNA测序。此外,使用CIBERSORT算法确定DN样本中免疫细胞浸润的比例。采用逆转录定量PCR(RT-qPCR)评估小鼠和DN患者肾脏中纤连蛋白1(FN1)的mRNA表达。沉默FN1后,通过RT-qPCR检测EMT标志物(E-钙黏蛋白和波形蛋白)的表达变化。FN1在DN中上调,根据ROC分析显示出良好的诊断性能。FN1与免疫细胞浸润相关。RT-qPCR证实了DN小鼠肾脏和DN患者肾活检样本中FN1表达增加。沉默FN1后,E-钙黏蛋白表达上调,而波形蛋白表达下调,表明EMT受到抑制。本研究确定FN1为DN的诊断标志物。FN1可能通过参与EMT和上调多种类型的免疫细胞在DN的发生和发展中起关键作用。